Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development.
作者信息
Raposo Bruno, Afonso Marcelo, Israelsson Lena, Wähämaa Heidi, Stålesen Ragnhild, Wermeling Fredrik, Hensvold Aase Haj, Grönwall Caroline, Rethi Bence, Klareskog Lars, Malmström Vivianne
机构信息
Department of Medicine, Karolinska Universitetssjukhuset i Solna, Stockholm, Sweden
Department of Medicine, Karolinska Universitetssjukhuset i Solna, Stockholm, Sweden.
出版信息
Ann Rheum Dis. 2023 May;82(5):724-726. doi: 10.1136/ard-2022-223417. Epub 2023 Jan 5.
Abstract
摘要
相似文献
1
Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development.
Ann Rheum Dis. 2023 May;82(5):724-726. doi: 10.1136/ard-2022-223417. Epub 2023 Jan 5.
2
The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
Ann Rheum Dis. 2014 Jun;73(6):1246-52. doi: 10.1136/annrheumdis-2012-202868. Epub 2013 May 1.
3
Benefits of anticitrullinated peptides examination in rheumatoid arthritis.
Niger J Clin Pract. 2018 Oct;21(10):1380-1383. doi: 10.4103/njcp.njcp_411_17.
4
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation.
Ann Rheum Dis. 2024 Feb 15;83(3):277-287. doi: 10.1136/ard-2023-224728.
5
Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Arthritis Res Ther. 2020 Jul 16;22(1):170. doi: 10.1186/s13075-020-02191-2.
6
Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
J Rheumatol. 2008 Oct;35(10):1972-7. Epub 2008 Sep 1.
7
Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
J Rheumatol. 2015 Nov;42(11):2023-8. doi: 10.3899/jrheum.150260. Epub 2015 Sep 1.
8
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Ann Rheum Dis. 2016 Jun;75(6):1139-44. doi: 10.1136/annrheumdis-2015-207326. Epub 2015 Oct 6.
9
Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.
Ann Rheum Dis. 2005 Sep;64(9):1316-20. doi: 10.1136/ard.2004.033548. Epub 2005 Mar 10.
10
Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
Ann Rheum Dis. 2016 Nov;75(11):1924-1932. doi: 10.1136/annrheumdis-2015-208579. Epub 2016 Jan 12.
引用本文的文献
1
Pain in systemic lupus erythematosus: emerging insights and paradigms.
Nat Rev Rheumatol. 2025 Aug 26. doi: 10.1038/s41584-025-01290-1.
2
Self-Antigens Select B Cells: A New Perspective on B Cell Selection and Function.
Eur J Immunol. 2025 Jul;55(7):e51720. doi: 10.1002/eji.202451720.
3
Anti-Peptidylarginine Deiminase 4 Autoantibodies Derived From Patients With Rheumatoid Arthritis Exert Pathogenic Effects by Activating Monocytes and Exacerbating Inflammatory Arthritis.
Arthritis Rheumatol. 2025 Apr 2. doi: 10.1002/art.43168.
4
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis.
Arthritis Rheumatol. 2025 Sep;77(9):1179-1193. doi: 10.1002/art.43161. Epub 2025 Apr 30.
5
Revisiting the Link Between HLA-DRB1 Alleles and Autoantibodies in Rheumatoid Arthritis: Association of non-Shared Epitope Alleles *09 and *15 With High Levels of Anti-Citrullinated Peptide/Protein Antibodies.
ACR Open Rheumatol. 2025 Jan;7(1):e11767. doi: 10.1002/acr2.11767. Epub 2024 Nov 22.
6
Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis.
Nat Rev Rheumatol. 2024 Oct;20(10):601-613. doi: 10.1038/s41584-024-01154-0. Epub 2024 Sep 9.
7
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases.
Immunol Rev. 2024 Nov;328(1):265-282. doi: 10.1111/imr.13390. Epub 2024 Sep 9.
8
An interdisciplinary perspective on peripheral drivers of pain in rheumatoid arthritis.
Nat Rev Rheumatol. 2024 Nov;20(11):671-682. doi: 10.1038/s41584-024-01155-z. Epub 2024 Sep 6.
9
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response.
RMD Open. 2024 Jul 22;10(3):e004411. doi: 10.1136/rmdopen-2024-004411.
10
The peculiar features, diversity and impact of citrulline-reactive autoantibodies.
Nat Rev Rheumatol. 2024 Jul;20(7):399-416. doi: 10.1038/s41584-024-01124-6. Epub 2024 Jun 10.
本文引用的文献
1
Combination of Two Monoclonal Anti-Citrullinated Protein Antibodies Induced Tenosynovitis, Pain, and Bone Loss in Mice in a Peptidyl Arginine Deiminase-4-Dependent Manner.
Arthritis Rheumatol. 2023 Feb;75(2):164-170. doi: 10.1002/art.42320. Epub 2022 Dec 9.
2
Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitization.
Pain. 2022 Aug 1;163(8):1542-1559. doi: 10.1097/j.pain.0000000000002543. Epub 2021 Nov 19.
3
Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
Arthritis Rheumatol. 2020 Oct;72(10):1643-1657. doi: 10.1002/art.41385. Epub 2020 Sep 10.
4
Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases.
Cell Mol Immunol. 2021 Jun;18(6):1528-1544. doi: 10.1038/s41423-020-0381-3. Epub 2020 Mar 20.
5
Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications.
Ann Rheum Dis. 2020 Apr;79(4):472-480. doi: 10.1136/annrheumdis-2019-216499. Epub 2020 Feb 10.
6
Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis.
Arthritis Rheumatol. 2018 Dec;70(12):1933-1945. doi: 10.1002/art.40590. Epub 2018 Oct 18.
7
Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.
Arthritis Rheumatol. 2014 Mar;66(3):513-22. doi: 10.1002/art.38273.
Zotero 插件